Pharvaris N.V. - stock earnings
PHVS Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q3 | -25.0 million USD | ? USD |
| 2023Q2 | 797098 USD | ? USD |
| 2023Q1 | -42.7 million USD | ? USD |
| 2022Q4 | -42.1 million USD | ? USD |
| 2022Q3 | -8.3 million USD | ? USD |
| 2022Q2 | -13.2 million USD | ? USD |
| 2022Q1 | -17.9 million USD | ? USD |
| 2021Q4 | -14.0 million USD | ? USD |
| 2021Q3 | -10.6 million USD | ? USD |
| 2021Q2 | -18.0 million USD | ? USD |
| 2021Q1 | -12.4 million USD | ? USD |
| 2020Q4 | -12.9 million USD | ? USD |
| 2020Q3 | -7.5 million USD | ? USD |
| 2020Q2 | -6.5 million USD | ? USD |
| 2020Q1 | -3.6 million USD | ? USD |
| 2019Q4 | -3.9 million USD | ? USD |
| 2019Q3 | -2.2 million USD | ? USD |
| 2019Q2 | -2.3 million USD | ? USD |
| 2019Q1 | -2.3 million USD | ? USD |
| 2018Q4 | -1.2 million USD | ? USD |
| 2018Q3 | -1.3 million USD | ? USD |
| 2018Q2 | -1.2 million USD | ? USD |
| 2018Q1 | -1.3 million USD | ? USD |
PHVS Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -118.6 million USD | ? USD |
| 2022 | -81.9 million USD | ? USD |
| 2021 | -48.6 million USD | ? USD |
| 2020 | -31.6 million USD | ? USD |
| 2019 | -9.0 million USD | ? USD |
| 2018 | -4.9 million USD | ? USD |
PHVS
Price: $22.68
52 week price:
Earnings Per Share: -3.28 USD
P/E Ratio: -9.48
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Volume: 38200
Market Capitalization: 1.2 billion